Effects of tamoxifen, toremifene and chloroquine on the lysosomal enzymes in cultured retinal pigment epithelial cells

Pharmacology and Toxicology

Volumn 83, Issue 6, 1998, Pages 246-251

  Toimela, Tarja ^a   Salminen, Lotta ^b   Tähti, Hanna ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CHLOROQUINE; LACTATE DEHYDROGENASE; N ACETYL BETA GLUCOSAMINIDASE; TAMOXIFEN; TAMOXIFEN CITRATE; TOREMIFENE;

ARTICLE; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PHAGOCYTOSIS; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA CELL; SWINE;

CICONIIFORMES; SUS SCROFA;

EID: 0031796729     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01477.x     Document Type: Article

References (32)

1. Anttila, M., R. Valavaara, S. Kivinen & J. Mäenpää: Pharmacokinetics of toremifene. J. Steroid Biochem. 1990, 36, 249-252.
2. Augereau, P., F. Miralles, V. Cavailles, C. Gaudelet, M. Parker & H. Rochefort: Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol. Endocrinol. 1994, 8, 693-703.
3. Augustijns, P., P. Geusens & N. Verbeke: Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis [see comments]. Eur. J. Clin. Pharmacol. 1992, 42, 429-433.
4. Bentley, C.R., G. Davies & W.A. Aclimandos: Tamoxifen retinopathy: a rare but serious complication. Brit. Med. J. 1992, 304, 495-496.
5. Boulton, M., P. Moriarty, J. Jarvis Evans & B. Marcyniuk: Regional variation and age-related changes of lysosomal enzymes in the human retinal pigment epithelium. Brit. J. Ophthalmol. 1994, 78, 125-129.
6. Bruinink, A., G. Zimmermann & F. Riesen: Neurotoxic effects of chloroquine in vitro. Arch. Toxicol. 1991, 65, 480-484.
7. Cabral, L., W. Unger, M. Boulton & J. Marshall: A microsystem to assay lysosomal enzyme activities in cultured retinal pigment epithelial cells. Curr. Eye Res. 1988, 7, 1097-1104.
8. Chern, S. & R. P. Danis: Retinopathy associated with low-dose tamoxifen [letter]. Amer. J. Ophthalmol. 1993, 116, 372-373.
9. el Hifnawi, E., W. Kuhnel, A. el Hifnawi & H. Laqua: Localization of lysosomal enzymes in the retina and retinal pigment epithelium of RCS rats. Anal. Anz. 1994, 176, 505-513.
10. Fredman, P., G. W. Klinghardt & L. Svennerholm: Effect of chloroquine on the activity of some lysosomal enzymes involved in ganglioside degradation. Biochim. Biophys. Acta 1987, 917, 1-8.
11. Gonzalez Noriega, A., J. H. Grubb, V. Talkad & W. S. Sly: Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling. J. Cell Biol. 1980, 85, 839-852.
12. Grady, L. H., D. J. Nonneman, G. E. Rottinghaus & W. V. Welshons: pH-dependent cytotoxicity of contaminants of phenol red for MCF-7 breast cancer cells. Endocrinology 1991, 129, 3321-3330.
13. Grant, W. M. & J.S. Schuman: Toxicology of the eye. Charles C. Thomas, Springfield, Illinois, USA, 1993, pp. 371-382.
14. Griffiths, M. F.: Tamoxifen retinopathy at low dosage. Amer. J. Ophthalmol. 1987, 104, 185-186.
15. Kangas, L.: Review of the pharmacological properties of toremifene. J. Steroid Biochem. 1990, 36, 191-195.
16. Karlsson, S., Y. Hirsimäki, E. Mäntylä, L. Nieminen, L. Kangas, P. Hirsimäki, C. J. Perry, M. Mulhern, P. Millar, J. Handa & G. M. Williams: A two-year dietary carcinogenicity study of the antiestrogen toremifene in Sprague-Dawley rats. Drug Chem. Toxicol. 1996, 19, 245-266.
17. Kelly, J. C., G. S. Wasserman, W. D. Bernard, C. Schultz & J. Knapp: Chloroquine poisoning in a child. Ann. Emerg. Med. 1990, 19, 47-50.
18. Kennedy, C. J., P. E. Rakoczy, T. A. Robertson, J. M. Papadimitriou & I. J. Constable: Kinetic studies on phagocytosis and lysosomal digestion of rod outer segments by human retinal pigment epithelial cells in vitro. Exp. Cell Res. 1994, 210, 209-214.
19. Lentrichia, B. B., Y. Itoh, J. J. Plantner & E. L. Kean: The influence of carbohydrates on the binding of rod outer-segment (ROS) disc membranes and intact ROS by the cells of the retinal pigment epithelium of the embryonic chick. Exp. Eye Res. 1987, 44, 127-142.
20. Lien, E. A., E. Solheim & P. M. Ueland: Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Res. 1991, 51, 4837-4844.
21. Matsumura, M., M. Ohkuma & I. Tsukahara: Experimental chloroquine retinopathy. Ophthalmic Res. 1986, 18, 172-179.
22. Miquelis, R., J. Courageot, A. Jacq, O. Blanck, C. Perrin & P. Bastiani: Intracellular routing of GLcNAc-bearing molecules in thyrocytes: selective recycling through the Golgi apparatus. J. Cell Biol. 1993, 123, 1695-1706.
23. Pavlidis, N. A., C. Petris, E. Briassoulis, G. Klouvas, C. Psilas, J. Rempapis & G. Petroutsos: Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer 1992, 69, 2961-2964.
24. Plantner, J. J. & E. L. Kean: Carbohydrate composition of bovine rhodopsin. J. Biol. Chem. 1976, 251, 1548-1552.
25. Ramkumar, T. & S. Adler: Differential positive and negative transcriptional regulation by tamoxifen. Endocrinology 1995, 136, 536-542.
26. Roman, S. D., C. J. Ormandy, D. L. Manning, R. W. Blamey, R. I. Nicholson, R. L. Sutherland & C. L. Clarke: Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res. 1993, 53, 5940-5945.
27. Schneider, P. Drug-induced lysosomal disorders in laboratory animals: new substances acting on lysosomes. Arch. Toxicol. 1992, 66, 23-33.
28. Sharon, N.: Carbohydrates as recognition determinants in phagocytosis and in lectin-mediated killing of target cells. Biol. Cell 1984, 51, 239-245.
29. Sheu, S. J., T. Sakamoto, R. Osusky, H. M. Wang, T. E. Ogden, S. J. Ryan, D. R. Hinton & R. Gopalakrishna: Transforming growth factor-beta regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathway. Graefes. Arch. Clin. Exp. Ophthalmol. 1994, 232, 695-701.
30. Stuart, N. S., P. Philip, A. L. Harris, K. Tonkin, S. Houlbrook, J. Kirk, E. A. Lien & J. Carmichael: High-dose tamoxifen as an enhancer of etoposide cytotoxicity. Clinical effects and in vitro assessment in p-glycoprotein expressing cell lines. Brit. J. Cancer 1992, 66, 833-839.
31. Tsuchiya, M., S. Hayasaka & K. Mizuno: Affinity of ocular acid-insoluble melanin for drugs in vitro. Invest. Ophthalmol. Vis. Sci. 1987, 28, 822-825.
32. Wiseman, H.: Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances. Trends. Pharmacol. Sci. 1994, 15, 83-89.